About a year ago, Anna DeLaRosby, PT, DPT, had a question for her former classmates from physical therapy school. A 2008 graduate of Clarke University, she had gone on to work at several different clinics and to become a physical therapy instructor herself.
By using this site, you are consenting to our use of cookies. To find out more visit our privacy policy.
Weighty Matters: Physical Therapy and GLP-1 Medications
What PTs need to know about working with patients taking glucagon-like peptide-1 agonists.
Date: Friday, August 1, 2025
Author:
Chris Hayhurst
Share This
Resource Details
Date: August 1, 2025
Contact: aptamag@apta.org
Content Type: Feature
Author(s)
Chris Hayhurst
You Might Also Like...
Article
New Study Reimagines the Relationship Between Daily Steps and Health OutcomesSep 3, 2025
For decades, 10,000 steps a day has been regarded as a near-universal benchmark for fitness and general health goals — often promoted by wearable fitness
News
Congress Is Back in Town: 5 Things to Watch on Capitol Hill in SeptemberSep 2, 2025
In July, APTA and other provider groups secured a 2.5% funding increase from Congress to the Medicare Physician Fee Schedule for 2026. While this was a
News
October Is National Physical Therapy Month: See How APTA Helps You CelebrateSep 2, 2025
APTA is recognizing National Physical Therapy Month in October by spotlighting the vital role physical therapy plays in improving movement for people of